Archiv

Cochrane Reviews

  • Kunath F, Jensen K, Pinart M, Kahlmeyer A, Schmidt S, Price CL, Lieb V, Dahm P. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer. Cochrane Database Syst Rev. 2019 Jun 11;6(6):CD003506.

  • Narayan V, Kahlmeyer A, Dahm P, Skoetz N, Risk MC, Bongiorno C, Patel N, Hwang EC, Jung JH, Gartlehner G, Kunath F. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review. Cochrane Database Syst Rev. 2018 Jul 23;7:CD012838.

  • Kunath F, Schmidt S, Krabbe LM, Miernik A, Dahm P, Cleves A, Walther M, Kroeger N. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. Cochrane Database Syst Rev. 2017 May 9;5:CD012045.

  • Kunath F, Grobe HR, Rücker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl JJ. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. Cochrane Database Syst Rev. 2014 Jun 30;6:CD009266.

  • PROTOKOLL: Degarelix for treating advanced hormone-sensitive prostate cancer Joachim J Jakob, Stefanie Schmidt , Frank Kunath , Joerg J Meerpohl , Anette Blümle , Christine Schmucker , Benjamin Mayer and Friedemann Zengerling Online Publication Date: February 2017.

  • PROTOKOLL: Tubeless versus tubed percutaneous nephrolithotomy for treating kidney stones Konrad Wilhelm , Simon Hein , Frank Kunath , Martin Schoenthaler and Stefanie Schmidt Online Publication Date: March 2017.


Systematische Reviews

  • Pinart M, Kunath F, Lieb V, Tsaur I, Wullich B, Schmidt S; German Prostate Cancer Consortium (DPKK). Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review. World J Urol. 2020 Mar;38(3):613-635. Epub 2018 Dec 15.

  • Kranz J, Schmidt S, Schneidewind L. Current Evidence on Nonantibiotic Prevention of Recurrent Urinary Tract Infections. Eur Urol Focus. 2018 Oct 3. pii: S2405-4569(18)30278-5.

  • Zengerling F, Kunath F, Jensen K, Ruf C, Schmidt S, Spek A. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review. Urol Oncol. 2018 Oct;36(10):448-458.

  • Pinart M, Kranz J, Jensen K, Proctor T, Naber K, Kunath F, Wagenlehner F, Schmidt S. Optimal dosage and duration of pivmecillinam treatment for uncomplicated lower urinary tract infections: a systematic review and meta-analysis. Int J Infect Dis. 2017 Mar 21. pii: S1201-9712(17)30095-4.

  • Kunath F, Borgmann H, Blümle A, Keck B, Wullich B, Schmucker C, Sikic D, Roelle C, Schmidt S, Wahba A, Meerpohl JJ. Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis. BMJ Open. 2015 Nov 13;5(11):e008217.


Leitlinien

  • Seitz C, Bach T, Bader M, Berg W, Knoll T, Neisius A, Netsch C, Nothacker M, Schmidt S, Schönthaler M, Siener R,  Stein R, Straub M, Strohmaier W, Türk C, Volkmer B. [Update of the 2Sk guidelines on the diagnostics, treatment and metaphylaxis of urolithiasis (AWMF register number 043-025): What is new?]. Urologe A. 2019 Nov;58(11):1304-1312.

  • Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K, Schmiemann G, Wagenlehner FM. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention. Urol Int. 2018;100(3):271-278.

  • Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, Helbig S, Vahlensieck W, Naber K, Schmiemann G, Wagenlehner FM. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part 1. Urol Int. 2018 Jan 17.

  • Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, Fünfstück R, Helbig S, Hofmann W, Hummers E, Kunze M, Kniehl E, Naber K, Mandraka F, Mündner-Hensen B, Schmiemann G, Wagenlehner FME. [Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline]. Urologe A. 2017 Jun;56(6):746-758.


Andere Publikationen

  • Pieper D, Ober P, Dressler C, Schmidt S, Mathes T, Becker M. [Increasing the efficiency of guideline production: a narrative review]. Z Evid Fortbild Qual Gesundhwes. 2019 Sep 26. pii: S1865-9217(19)30132-1.

  • Schoeb DS, Wullich B, Dürschmied D, Heimbach B, Heupel-Reuter M, Gross AJ, Wilhelm K, Gratzke C, Miernik A. [Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines]. Urologe A. 2019 Sep;58(9):1029-1038.

  • Kranz J, Schmidt S, Lebert C, Schneidewind L, Schmiemann G, Wagenlehner F. Uncomplicated Bacterial Communityacquired Urinary Tract Infection in Adults. Dtsch Arztebl Int. 2017 Dec 15;114(50):866-873.

  • Kranz J, Helbig S, Mandraka F, Schmidt S, Naber KG. The revival of old antibiotics for treatment of uncomplicated urinary tract infections in the era of antibiotic stewardship. Curr Opin Urol. 2017 Mar;27(2):127-132.


Sonstige Publikationen

2022

2021

2019

2018

  2017

 2016

2015